Publication
Article
BioPharm International
Getting Biopharmaceutical Tech Transfer Right the First Time
Author(s):
Good project management, budgeting, planning, and clear documentation are the only ways to prevent overruns and project failure.
Biopharmaceutical experts Stephen Perry, CEO of Kymanox, James Blackwell, principal consultant with The Windshire Group, and consultant Mike Ultee, share best practices and musts to avoid in biopharmaceutical technology transfer. Some crucial takeaways? Share all data (especially data on failed runs in the past), and include clear instructions for sampling. In addition, aim for reproducibility.
Download BioPharm International's
2017 Outsourcing Resources eBook.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
